chartexchange

RARE
Ultragenyx Pharmaceutical Inc.
stockNASDAQ

Market OpenNov 19, 2026 9:46:17 AM EST
17.57USD-0.902%(-0.16)87,541
Pre-marketNov 19, 2026 9:17:30 AM EST
17.70USD-0.169%(-0.03)
17.50Bid17.65Ask0.15Spread

RARE Financials

In Q3 FY 2026 (ended ), Ultragenyx Pharmaceutical Inc. (RARE) reported revenue of $173M, net income of −$118M, operating cash flow of −$43M, and assets of $1.19B (filed ).

Loading financial statements…